ADIM
ALB icon

Alpha DNA Investment Management’s Albemarle ALB Stock Holding History

Alpha DNA Investment Management’s Portfolio ALB Stock Details ALB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-2,632
Closed -$696K – 151
2022
Q3 		$696K Sell
2,632
-2,931
-53% -$745K 0.58% 63
2022
Q2 		$1.16M Buy
+5,563
New +$1.24M 0.99% 19
2021
Q2 		– Sell
-8
Closed -$1K – 120
2021
Q1 		$1K Buy
+8
New +$1.28K ﹤0.01% 603

Other funds holding ALB

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Alpha DNA Investment Management's ALB Position: Q4 2022 in Review

Alpha DNA Investment Management sold out of Albemarle (ALB) in Q4 2022, closing a stake of 2,632 shares — an estimated $696K sold.

Alpha DNA Investment Management first reported a position in ALB in Q1 2021 and held it in 3 quarters. The position peaked at $1.16M in Q2 2022. 1,020 funds tracked by Wall St. Rank hold ALB as of Q4 2022.

  • Alpha DNA Investment Management reported no remaining Albemarle position as of Q4 2022 after selling out during the quarter.
  • Alpha DNA Investment Management sold 2,632 Albemarle shares in Q4 2022, an estimated $696K.
  • Alpha DNA Investment Management first reported a position in Albemarle in Q1 2021 and held it in 3 quarters.
  • Alpha DNA Investment Management's Albemarle position peaked at $1.16M in Q2 2022.
  • 1,020 funds tracked by Wall St. Rank held Albemarle as of Q4 2022.

Based on Alpha DNA Investment Management's 13F filing for Q4 2022, filed 27 Jan 2023.